2
|
Chandra T, Zebrowski JP, Lenertz LY. Safe Handling of Cannulas and Needles in Chemistry Laboratories. ACS CHEMICAL HEALTH & SAFETY 2022. [DOI: 10.1021/acs.chas.1c00069] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Tilak Chandra
- Department of Environment, Health and Safety, University of Wisconsin−Madison, 21 North Park, Madison, Wisconsin 53715, United States
| | - Jeffrey P. Zebrowski
- Department of Environment, Health and Safety, University of Wisconsin−Madison, 21 North Park, Madison, Wisconsin 53715, United States
| | - Lisa Y. Lenertz
- Department of Environment, Health and Safety, University of Wisconsin−Madison, 21 North Park, Madison, Wisconsin 53715, United States
| |
Collapse
|
3
|
Chandra T, Zebrowski JP, McClain R, Lenertz LY. Generating Standard Operating Procedures for the Manipulation of Hazardous Chemicals in Academic Laboratories. ACS CHEMICAL HEALTH & SAFETY 2020. [DOI: 10.1021/acs.chas.0c00092] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Tilak Chandra
- Department of Environment Health and Safety, University of Wisconsin—Madison, 30 East Campus Mall, Madison, Wisconsin 53715, United States
| | - Jeffrey P. Zebrowski
- Department of Environment Health and Safety, University of Wisconsin—Madison, 30 East Campus Mall, Madison, Wisconsin 53715, United States
| | - Rob McClain
- Department of Chemistry, University of Wisconsin—Madison, Madison, Wisconsin 53706, United States
| | - Lisa Y. Lenertz
- Department of Environment Health and Safety, University of Wisconsin—Madison, 30 East Campus Mall, Madison, Wisconsin 53715, United States
| |
Collapse
|
6
|
Karlsson S, Gardelli C, Lindhagen M, Nikitidis G, Svensson T. Route Optimization and Manufacture of Multihundred Grams of a Ghrelin Receptor Agonist. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00179] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Staffan Karlsson
- Early Chemical Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca Gothenburg, SE-431 83 Mölndal, Sweden
| | - Cristina Gardelli
- Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca Gothenburg, SE-431 83 Mölndal, Sweden
| | - Marika Lindhagen
- Early Chemical Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca Gothenburg, SE-431 83 Mölndal, Sweden
| | - Grigorios Nikitidis
- Early Chemical Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca Gothenburg, SE-431 83 Mölndal, Sweden
| | - Tor Svensson
- Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca Gothenburg, SE-431 83 Mölndal, Sweden
| |
Collapse
|
7
|
Good JAD, Silver J, Núñez-Otero C, Bahnan W, Krishnan KS, Salin O, Engström P, Svensson R, Artursson P, Gylfe Å, Bergström S, Almqvist F. Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity. J Med Chem 2016; 59:2094-108. [PMID: 26849778 DOI: 10.1021/acs.jmedchem.5b01759] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The bacterial pathogen Chlamydia trachomatis is a global health burden currently treated with broad-spectrum antibiotics which disrupt commensal bacteria. We recently identified a compound through phenotypic screening that blocked infectivity of this intracellular pathogen without host cell toxicity (compound 1, KSK 120). Herein, we present the optimization of 1 to a class of thiazolino 2-pyridone amides that are highly efficacious (EC50 ≤ 100 nM) in attenuating infectivity across multiple serovars of C. trachomatis without host cell toxicity. The lead compound 21a exhibits reduced lipophilicity versus 1 and did not affect the growth or viability of representative commensal flora at 50 μM. In microscopy studies, a highly active fluorescent analogue 37 localized inside the parasitiphorous inclusion, indicative of a specific targeting of bacterial components. In summary, we present a class of small molecules to enable the development of specific treatments for C. trachomatis.
Collapse
Affiliation(s)
- James A D Good
- Department of Chemistry, Umeå University , 901 87 Umeå, Sweden.,Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden
| | - Jim Silver
- Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden.,Department of Molecular Biology, Umeå University , 901 87 Umeå, Sweden.,Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University , 901 87 Umeå, Sweden
| | - Carlos Núñez-Otero
- Department of Clinical Microbiology, Umeå University , 901 85 Umeå, Sweden
| | - Wael Bahnan
- Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden.,Department of Molecular Biology, Umeå University , 901 87 Umeå, Sweden.,Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University , 901 87 Umeå, Sweden
| | - K Syam Krishnan
- Department of Chemistry, Umeå University , 901 87 Umeå, Sweden.,Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden
| | - Olli Salin
- Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden.,Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University , 901 87 Umeå, Sweden.,Department of Clinical Microbiology, Umeå University , 901 85 Umeå, Sweden
| | - Patrik Engström
- Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden.,Department of Molecular Biology, Umeå University , 901 87 Umeå, Sweden.,Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University , 901 87 Umeå, Sweden
| | - Richard Svensson
- Department of Pharmacy, Uppsala University , SE-751 23 Uppsala, Sweden.,The Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Chemical Biology Consortium Sweden, Uppsala University , SE-751 23 Uppsala, Sweden
| | - Per Artursson
- Department of Pharmacy, Uppsala University , SE-751 23 Uppsala, Sweden.,The Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Chemical Biology Consortium Sweden, Uppsala University , SE-751 23 Uppsala, Sweden
| | - Åsa Gylfe
- Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden.,Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University , 901 87 Umeå, Sweden.,Department of Clinical Microbiology, Umeå University , 901 85 Umeå, Sweden
| | - Sven Bergström
- Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden.,Department of Molecular Biology, Umeå University , 901 87 Umeå, Sweden.,Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University , 901 87 Umeå, Sweden
| | - Fredrik Almqvist
- Department of Chemistry, Umeå University , 901 87 Umeå, Sweden.,Umeå Centre for Microbial Research, Umeå University , 901 87 Umeå, Sweden
| |
Collapse
|
8
|
Dunetz JR, Magano J, Weisenburger GA. Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals. Org Process Res Dev 2016. [DOI: 10.1021/op500305s] [Citation(s) in RCA: 411] [Impact Index Per Article: 51.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Joshua R. Dunetz
- Process
Chemistry, Gilead Sciences, 333 Lakeside Drive, Foster City, California 94404, United States
| | - Javier Magano
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Gerald A. Weisenburger
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
9
|
Abrahamsson K, Andersson P, Bergman J, Bredberg U, Brånalt J, Egnell AC, Eriksson U, Gustafsson D, Hoffman KJ, Nielsen S, Nilsson I, Pehrsson S, Polla MO, Skjaeret T, Strimfors M, Wern C, Ölwegård-Halvarsson M, Örtengren Y. Discovery of AZD8165 – a clinical candidate from a novel series of neutral thrombin inhibitors. MEDCHEMCOMM 2016. [DOI: 10.1039/c5md00479a] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A novel series of neutral thrombin inhibitors has been developed using a selection process based on docking experiments and property calculations and predictions.
Collapse
|